A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.
Experimental Treatment Acquiring Popularity Via Social Media
The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are urged to contact these accounts privately for source information, while also receiving discount codes.
Active Commerce on Messaging Platforms
Separately, a flourishing trade exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and claims of next-day British shipping. Sellers market the drug there before directing customers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Medical Professionals Express Worries
Nevertheless, physicians and chemists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to individuals administering products of unknown origin.
Several experts stated the popularity for the experimental drug could be linked to the increasing cost of licensed weight loss products such as Mounjaro.
Regulatory Status and Enforcement
Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers try to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate medicines, advertising, and customer laws, potentially leading to fines, prosecution or imprisonment.
Service Response and Material Elimination
Based on TikTok, the platform has taken down problematic material and prohibited related keywords and search suggestions. The company said it was committed to maintaining the service secure and investing in enhancing enforcement strategies.
Digital Marketplace Operations
Investigations also discovered groups with up to 9,000 members marketing retatrutide using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of users, filled with images of weight loss, glowing testimonials and detailed guides for preparing or injecting at residence.
Within minutes of entering one community, a vendor posted contact information, where most purchases take place. The seller sent an instruction manual and guaranteed shipping within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about body mass, health issues or past usage.
Product Details and Pricing
Within these groups, posts show black plastic packages with Royal Mail labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors usually priced at £160 for 20mg. When questioned how long a pen should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.
Service Moderation and Security Measures
A spokesperson for Telegram stated it regularly monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are administering materials they cannot confirm. Even if the research behind retatrutide is sound, these digital versions may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, patients are using online platforms. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.
Her staff has already seen patients injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”
Producer Position
A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental product not yet approved … may expose users to potentially significant health risks”.
